2024-07-05 15:39:25 ET
Summary
- Edwards Lifesciences Corporation is a top-quality company with strong growth in heart-related products and solid financial performance.
- The company has shown consistent revenue growth and margin improvement over the years, resulting in premium valuations, rightfully deserved so.
- The recent sale of the Critical Care unit and focus on strategic growth investments indicate a positive outlook for the company's future performance.
In the spring of last year, I called Edwards Lifesciences Corporation ( EW ) a solid, yet not too spectacular performer. The company had seen a very solid year, while its current growth prospects were very solid. This looked quite compelling, although Edwards sold its Critical Care business a bit on the cheap, in my belief....
Read the full article on Seeking Alpha
For further details see:
Edwards Lifesciences: Focus On The Heart